Part 1 Beginner Why long-term crypto holders borrow against assets instead of selling A strategic guide to liquidity management, capital preservation, and the real tradeoff between selling and borrowing crypto Open guide
CryptoGamesFollow the latest crypto headlines, top categories, and market-moving stories.
Circle adds $3 billion Wall Street Arc token risking an uncomfortable rivalry with Coinbase Enterprise May 12, 2026 Explore why savvy investors borrow against crypto instead of selling, with insights on liquidity, capital preservation, and portfolio strategy.
Part 1 Beginner Why long-term crypto holders borrow against assets instead of selling A strategic guide to liquidity management, capital preservation, and the real tradeoff between selling and borrowing crypto Open guide
Part 2 Beginner Why collateral reuse is the hidden risk in crypto lending Rehypothecation is a core risk in crypto lending. Learn how collateral reuse works, why it has amplified past failures, and how to evaluate safer platforms. Open guide Explore CryptoSlate’s Institutional Playbook, a 3-part guide series on exchange due diligence, crypto-as-a-service, and token listing strategy for institutional teams.
Part 1 Advanced The Market Maker’s Exchange Checklist (Liquidity, Latency, and Risk Controls) Market makers and HFT desks: evaluate exchanges on execution quality, liquidity, latency, fees, margin, and security — with a WhiteBIT walkthrough. Open guide
Part 2 Advanced Crypto-as-a-Service Playbook: How Banks, Telcos, and Fintechs Launch Crypto Products Fast, Safely, and Compliantly An institutional playbook for launching crypto via CaaS: architecture, phased rollout, security, compliance, payments, KPIs, and vendor diligence. Open guide
Part 3 Advanced Token Listing Playbook — How Projects Prepare for a CEX Listing and Sustain Healthy Liquidity A practical playbook for crypto teams to prepare for a CEX listing: readiness, integration, liquidity, market making, launch comms, and post-listing ops. Open guide Browse trusted reviews across exchanges, casinos, wallets, cards, and more.
Company resources, help, legal information, and ways to follow CryptoSlate.
Circle adds $3 billion Wall Street Arc token risking an uncomfortable rivalry with Coinbase Enterprise Neutral May 12, 2026
Hormuz oil contagion spreads to 8 major economies and Bitcoin has just one route through Macro Bearish May 12, 2026
OpenAI’s new cybersecurity push has a lesson for crypto: stop waiting for the hack AI Neutral May 12, 2026
Washington insider warns US defeat in Iran now “likely” – adding a new macro risk for Bitcoin Macro Bearish May 12, 2026
Buy Borrow Die Why long-term crypto holders borrow against assets instead of selling
Buy Borrow Die Why collateral reuse is the hidden risk in crypto lending
Institutional Playbook The Market Maker’s Exchange Checklist (Liquidity, Latency, and Risk Controls)
Institutional Playbook Crypto-as-a-Service Playbook: How Banks, Telcos, and Fintechs Launch Crypto Products Fast, Safely, and Compliantly
Institutional Playbook Token Listing Playbook — How Projects Prepare for a CEX Listing and Sustain Healthy Liquidity 
China Merchants Bank’s Hong Kong unit moves a money market product onto BNB Chain. What it means for custody, redemptions, and ETH/SOL competition.
Gino Matos 4 min read
Amidst market upheaval, Binance's $283 million compensation bolsters BNB's remarkable recovery.
BNB Chain's expanding value and robust trading volumes fuel BNB's rise to third-largest crypto, overtaking XRP.
This unlikely memecoin windfall reflects the pitfalls and promises of speculative social sentiment trading.
Early investors reap rewards as BNB's rally hits 1,000x returns amid supportive macroeconomic trends.
BNB posted 29% gains in 2025 alone and 191% growth since 2024, establishing itself as the standout performer among major altcoins from the 2017 cycle.
A Hong Kong bank, a U.S. small cap and new funds pile into multi-chain assets.
By adding high-liquidity tokens as collateral, Ethena Labs aims to minimize risks and boost USDe stability.
Biotech firm Windtree Therapeutics is facing imminent delisting from Nasdaq after its share price fell below the minimum threshold.